aap Implantate AG ("aap" or the "Company") had invited its shareholders to the Annual General Meeting on July 25, 2023, at the Panorama Congress Center at Wernerwerk in Berlin.
In the Ernst von Siemens Hall, the chairman of the meeting and chairwoman of the Supervisory Board, Dr. med. Nathalie Krebs, welcomed the shareholders and guests. Following the speech by the Management Board, CEO Rubino di Girolamo, CFO Marek Hahn and COO Agnieszka Mierzejewska answered the shareholders' questions about the Group and the course of business.
Of the Company's capital stock, 62.61 percent was represented. The shareholders approved the items on the agenda with large majorities (all agenda items put to the vote had approval rates of over 99 percent). In addition to the ratification of the actions of the Management Board and Supervisory Board, the election of the auditor, an amendment to the Articles of Association to allow virtual Annual General Meetings, the compensation report for the Management Board and Supervisory Board, and an authorization to acquire and use treasury shares, the resolution on the creation of a new Authorized Capital 2023/I was also put to the vote.
"I am very pleased with the results of the Annual General Meeting and, on behalf of the entire Management Board, would like to thank our shareholders for their trust and support," says Rubino Di Girolamo, Chairman / CEO of aap. "We see this as a clear appreciation of the performance of the management and employees of the company in further challenging times. We also see these results as a sign of support for the corporate strategy pursued, both in terms of short-term performance metrics and long-term value creation."
The voting results on the agenda items are published on the aap website under Investors / Annual General Meeting.------------------------------------------------------
aap Implantate AG (ISIN DE0005066609) - General Standard/Regulated Market - All German Stock Exchanges -
